Mohammad Zen Rahfiludin
Department of Public Health Nutrition, Universitas Diponegoro, Semarang, Indonesia

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Understanding the Barriers to Exclusive Breastfeeding Among Urban Indonesian Mothers Irmawati Irmawati; Mohammad Zen Rahfiludin; Zefan Adiputra Golo; Adhani Windari; Malihah Ramadhani Rum; Risky Kusuma Hartono
Media Kesehatan Masyarakat Indonesia Vol. 21 No. 1: MARCH 2025
Publisher : Faculty of Public Health, Hasanuddin University, Makassar

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30597/mkmi.v21i1.42145

Abstract

Despite WHO recommendations advocating for Exclusive Breastfeeding (EBF) for the initial six months, EBF rates remain low in many countries, including Indonesia. This study identifies psychosocial, socioeconomic, and demographic factors influencing EBF practices in Semarang City. Methods: A quasi-experimental design involved 157 participants (98 mother-infant pairs and 49 peers) recruited from various public health centres from December 2023 to June 2024. The Kaplan-Meier survival curve, in conjunction with the log-rank test, was employed to assess the disparities in survival and the observed practices of EBF. The determinants of EBF duration were found using the cox proportional hazard ratio. Results: The mean duration of EBF was 18 weeks, a number of 33.7% of mothers did not complete full six months. Key findings reveal that peer support, maternal knowledge, attitudes, skills, education level, and employment status significantly influence EBF duration. Mothers who received peer support had greater EBF resilience compared to those who did not received peer support (HR 0,32, CI:0.197,0.528). Practical skill, favourable attitudes, and high knowledge were also important indicators of sustained EBF. Conversely, being a working mother and having lower education level increased the risk of early EBF cessation. Conclusions: The results emphasize the necessity of focused, context-specific interventions to promote EBF in urban areas. These insights carry implications for policy and program development aimed to enhance health consequences for mother and children. Further research in diverse socio-demographic contexts is recommended to better understand and support effective EBF practices.
Dose-Response Moringa Oleifera Extracts on Lactation Outcomes In Breastfeeding Women Irmawati Irmawati; Mohammad Zen Rahfiludin
Jurnal Kesehatan Masyarakat Vol. 21 No. 4 (2026)
Publisher : Universitas Negeri Semarang in collaboration with Ikatan Ahli Kesehatan Masyarakat Indonesia (IAKMI Tingkat Pusat) and Jejaring Nasional Pendidikan Kesehatan (JNPK)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.15294/kemas.v21i4.40624

Abstract

Introduction: Herbal galactagogues such as Moringa oleifera are traditionally used to enhance breast milk production. However, evidence regarding optimal dosage is limited. This study aimed to evaluate the effects of three different doses of Moringa oleifera extract (250 mg, 650 mg, and 800 mg) on breast milk production in breastfeeding mothers. Methods: a quasi-experimental pretest posttest was conducted among 89 postpartum women from three Primary Health Centre areas in Semarang, Central Java, Indonesia. Participants received 250 mg (n=28), 650 mg (n=30), or 800 mg (n=31) of Moringa oleifera extract once daily for 14 days. Outcomes were infant weight gain, bowel movement frequency, and urination frequency. Data were collected from October 2024 to March 2025 and analysed using paired t tests and Kruskal-Wallis tests (p<0.05). Results: All dosage groups showed improvements in indicators of breast milk production. No statistically significant differences were observed between groups (p>0,05). The 650 mg group recorded the highest mean infant weight gain, whereas the 250 mg group showed the greatest increases in bowel movements and urination frequency. Conclusions: Moringa oleifera extract at 250, 650, and 800 mg/day over 14 days supported breast-milk production. Further studies are needed to clarify the dose response relationship.